Advertisements
Advertisements
Question
The first clinical gene therapy was done for the treatment of ________.
Options
AIDS
Cancer
Cystic fibrosis
SCID
Advertisements
Solution
The first clinical gene therapy was done for the treatment of SCID.
Explanation:
The first clinical gene therapy was performed to treat SCID (severe combination immune deficiency) caused by an ADA deficiency.
APPEARS IN
RELATED QUESTIONS
Why do children cured by enzyme-replacement therapy adenosine deaminase deficiency need periodic treatment?
Compare and contrast the advantages and disadvantages of the production of genetically modified crops.
State the cause of ADA deficiency in humans.Mention a possible cure for an ADA deficiency patient.
State the best-known contribution of P.K. Sethi
What is gene therapy? Name the first clinical case in which it was used.
Give a schematic representation of the transformation of a pro-insulin into insulin.
Describe the role of primers.
The genetic defect adenosine deaminase deficiency may be cured permanently by ____________.
Vaccines that use components of a pathogenic organism rather than the whole organism are called ____________.
Explain how recombinant Insulin can be produced.
A patient suffering from diabetes mellitus will have ______.
Which of the following is a neuropeptide hormone?
A pathophysiology is the ______.
Which of the following is the correct sequence of steps in a PCR (Polymerase Chain Reaction)?
How is a mature, functional insulin hormone different from its prohormone form?
Name the five key tools for accomplishing the tasks of recombinant DNA technology. Also mention the functions of each tool.
How does a gene therapy involving direct modification of the cells, in order to achieve a therapeutic goal is used in the treatment of ADA deficiency? Explain.
Give a reason for the following:
Streptokinase is administered to the patients having myocardial infarction.
How many cycles of PCR are required to produce 250 molecules of DNA, starting with a single parental strand?
